Global Mycoplasma Testing Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	July, 2023	INF18150218

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	July, 2023
SKU	INF18150218

Global Mycoplasma Testing Market 2023-2027

The mycoplasma testing market is forecasted to grow by USD 645.51 mn during 2022-2027, accelerating at a CAGR of 12.25% during the forecast period. The report on the mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on R and D of biopharmaceuticals, growing geriatric population, and rise in adoption of real-time mycoplasma testing.

Technavio's mycoplasma testing market is segmented as below:

By End-user

Pharmaceutical and biotechnology comp.
Cell banks
Academic research institutes
CROs
Others

By Product

Consumables
Systems

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising strategic alliances by vendors as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, the rising prevalence of mycoplasma pneumonia and concerns associated with pneumonia mortality and increasing initiatives for rapid diagnostics of infectious diseases will lead to sizable demand in the market.

The report on the mycoplasma testing market covers the following areas:

Mycoplasma testing market sizing
Mycoplasma testing market forecast
Mycoplasma testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Akron Biotechnology LLC, Becton Dickinson and Co., Bio Techne Corp., Bionique Testing Laboratories Inc., Charles River Laboratories International Inc., DiaSorin SpA, Dilarus GmbH, F. Hoffmann La Roche Ltd., GeneCopoeia Inc., InvivoGen Corp., Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., PromoCell GmbH, Sartorius AG, ScienCell Research Laboratories Inc., SGS SA, and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Product; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global mycoplasma testing market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on global mycoplasma testing market 2017 - 2021 ($ million); 4.2 End-user Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million); 4.3 Product Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2022-2027 (%); Exhibit 31: Data Table on End-user - Market share 2022-2027 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027; Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%); 6.4 Cell banks - Market size and forecast 2022-2027; Exhibit 38: Chart on Cell banks - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Cell banks - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Cell banks - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Cell banks - Year-over-year growth 2022-2027 (%); 6.5 Academic research institutes - Market size and forecast 2022-2027; Exhibit 42: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million); Exhibit 43: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million); Exhibit 44: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%); Exhibit 45: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%); 6.6 CROs - Market size and forecast 2022-2027; Exhibit 46: Chart on CROs - Market size and forecast 2022-2027 ($ million); Exhibit 47: Data Table on CROs - Market size and forecast 2022-2027 ($ million); Exhibit 48: Chart on CROs - Year-over-year growth 2022-2027 (%); Exhibit 49: Data Table on CROs - Year-over-year growth 2022-2027 (%); 6.7 Others - Market size and forecast 2022-2027; Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.8 Market opportunity by End-user; Exhibit 54: Market opportunity by End-user ($ million); Exhibit 55: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Exhibit 56: Chart on Product - Market share 2022-2027 (%); Exhibit 57: Data Table on Product - Market share 2022-2027 (%); 7.2 Comparison by Product; Exhibit 58: Chart on Comparison by Product; Exhibit 59: Data Table on Comparison by Product; 7.3 Consumables - Market size and forecast 2022-2027; Exhibit 60: Chart on Consumables - Market size and forecast 2022-2027 ($ million); Exhibit 61: Data Table on Consumables - Market size and forecast 2022-2027 ($ million); Exhibit 62: Chart on Consumables - Year-over-year growth 2022-2027 (%); Exhibit 63: Data Table on Consumables - Year-over-year growth 2022-2027 (%); 7.4 Systems - Market size and forecast 2022-2027; Exhibit 64: Chart on Systems - Market size and forecast 2022-2027 ($ million); Exhibit 65: Data Table on Systems - Market size and forecast 2022-2027 ($ million); Exhibit 66: Chart on Systems - Year-over-year growth 2022-2027 (%); Exhibit 67: Data Table on Systems - Year-over-year growth 2022-2027 (%); 7.5 Market opportunity by Product; Exhibit 68: Market opportunity by Product ($ million); Exhibit 69: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 73: Chart on Geographic comparison; Exhibit 74: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 Asia - Market size and forecast 2022-2027; Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 UK - Market size and forecast 2022-2027; Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.9 Canada - Market size and forecast 2022-2027; Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%); 9.10 Germany - Market size and forecast 2022-2027; Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.11 China - Market size and forecast 2022-2027; Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ million); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 Agilent Technologies Inc.; Exhibit 119: Agilent Technologies Inc. - Overview; Exhibit 120: Agilent Technologies Inc. - Business segments; Exhibit 121: Agilent Technologies Inc. - Key offerings; Exhibit 122: Agilent Technologies Inc. - Segment focus; 12.4 ATCC; Exhibit 123: ATCC - Overview; Exhibit 124: ATCC - Product / Service; Exhibit 125: ATCC - Key offerings; 12.5 Akron Biotechnology LLC; Exhibit 126: Akron Biotechnology LLC - Overview; Exhibit 127: Akron Biotechnology LLC - Product / Service; Exhibit 128: Akron Biotechnology LLC - Key offerings; 12.6 Becton Dickinson and Co.; Exhibit 129: Becton Dickinson and Co. - Overview; Exhibit 130: Becton Dickinson and Co. - Business segments; Exhibit 131: Becton Dickinson and Co. - Key news; Exhibit 132: Becton Dickinson and Co. - Key offerings; Exhibit 133: Becton Dickinson and Co. - Segment focus; 12.7 Bio Techne Corp.; Exhibit 134: Bio Techne Corp. - Overview; Exhibit 135: Bio Techne Corp. - Business segments; Exhibit 136: Bio Techne Corp. - Key news; Exhibit 137: Bio Techne Corp. - Key offerings; Exhibit 138: Bio Techne Corp. - Segment focus; 12.8 Bionique Testing Laboratories Inc.; Exhibit 139: Bionique Testing Laboratories Inc. - Overview; Exhibit 140: Bionique Testing Laboratories Inc. - Product / Service; Exhibit 141: Bionique Testing Laboratories Inc. - Key offerings; 12.9 Charles River Laboratories International Inc.; Exhibit 142: Charles River Laboratories International Inc. - Overview; Exhibit 143: Charles River Laboratories International Inc. - Business segments; Exhibit 144: Charles River Laboratories International Inc. - Key news; Exhibit 145: Charles River Laboratories International Inc. - Key offerings; Exhibit 146: Charles River Laboratories International Inc. - Segment focus; 12.10 F. Hoffmann La Roche Ltd.; Exhibit 147: F. Hoffmann La Roche Ltd. - Overview; Exhibit 148: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 149: F. Hoffmann La Roche Ltd. - Key news; Exhibit 150: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 151: F. Hoffmann La Roche Ltd. - Segment focus; 12.11 GeneCopoeia Inc.; Exhibit 152: GeneCopoeia Inc. - Overview; Exhibit 153: GeneCopoeia Inc. - Product / Service; Exhibit 154: GeneCopoeia Inc. - Key offerings; 12.12 InvivoGen Corp.; Exhibit 155: InvivoGen Corp. - Overview; Exhibit 156: InvivoGen Corp. - Product / Service; Exhibit 157: InvivoGen Corp. - Key offerings; 12.13 Lonza Group Ltd.; Exhibit 158: Lonza Group Ltd. - Overview; Exhibit 159: Lonza Group Ltd. - Business segments; Exhibit 160: Lonza Group Ltd. - Key news; Exhibit 161: Lonza Group Ltd. - Key offerings; Exhibit 162: Lonza Group Ltd. - Segment focus; 12.14 Merck KGaA; Exhibit 163: Merck KGaA - Overview; Exhibit 164: Merck KGaA - Business segments; Exhibit 165: Merck KGaA - Key news; Exhibit 166: Merck KGaA - Key offerings; Exhibit 167: Merck KGaA - Segment focus; 12.15 Norgen Biotek Corp.; Exhibit 168: Norgen Biotek Corp. - Overview; Exhibit 169: Norgen Biotek Corp. - Product / Service; Exhibit 170: Norgen Biotek Corp. - Key offerings; 12.16 Sartorius AG; Exhibit 171: Sartorius AG - Overview; Exhibit 172: Sartorius AG - Business segments; Exhibit 173: Sartorius AG - Key news; Exhibit 174: Sartorius AG - Key offerings; Exhibit 175: Sartorius AG - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Exhibit 176: Thermo Fisher Scientific Inc. - Overview; Exhibit 177: Thermo Fisher Scientific Inc. - Business segments; Exhibit 178: Thermo Fisher Scientific Inc. - Key news; Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 181: Inclusions checklist; Exhibit 182: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 183: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 184: Research methodology; Exhibit 185: Validation techniques employed for market sizing; Exhibit 186: Information sources; 13.5 List of abbreviations; Exhibit 187: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on global mycoplasma testing market 2017 - 2021 ($ million); Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on End-user - Market share 2022-2027 (%); Exhibits31: Data Table on End-user - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Cell banks - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Cell banks - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Cell banks - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Cell banks - Year-over-year growth 2022-2027 (%); Exhibits42: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million); Exhibits43: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million); Exhibits44: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%); Exhibits45: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%); Exhibits46: Chart on CROs - Market size and forecast 2022-2027 ($ million); Exhibits47: Data Table on CROs - Market size and forecast 2022-2027 ($ million); Exhibits48: Chart on CROs - Year-over-year growth 2022-2027 (%); Exhibits49: Data Table on CROs - Year-over-year growth 2022-2027 (%); Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits54: Market opportunity by End-user ($ million); Exhibits55: Data Table on Market opportunity by End-user ($ million); Exhibits56: Chart on Product - Market share 2022-2027 (%); Exhibits57: Data Table on Product - Market share 2022-2027 (%); Exhibits58: Chart on Comparison by Product; Exhibits59: Data Table on Comparison by Product; Exhibits60: Chart on Consumables - Market size and forecast 2022-2027 ($ million); Exhibits61: Data Table on Consumables - Market size and forecast 2022-2027 ($ million); Exhibits62: Chart on Consumables - Year-over-year growth 2022-2027 (%); Exhibits63: Data Table on Consumables - Year-over-year growth 2022-2027 (%); Exhibits64: Chart on Systems - Market size and forecast 2022-2027 ($ million); Exhibits65: Data Table on Systems - Market size and forecast 2022-2027 ($ million); Exhibits66: Chart on Systems - Year-over-year growth 2022-2027 (%); Exhibits67: Data Table on Systems - Year-over-year growth 2022-2027 (%); Exhibits68: Market opportunity by Product ($ million); Exhibits69: Data Table on Market opportunity by Product ($ million); Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits73: Chart on Geographic comparison; Exhibits74: Data Table on Geographic comparison; Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%); Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits111: Market opportunity By Geographical Landscape ($ million); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits113: Impact of drivers and challenges in 2022 and 2027; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: Agilent Technologies Inc. - Overview; Exhibits120: Agilent Technologies Inc. - Business segments; Exhibits121: Agilent Technologies Inc. - Key offerings; Exhibits122: Agilent Technologies Inc. - Segment focus; Exhibits123: ATCC - Overview; Exhibits124: ATCC - Product / Service; Exhibits125: ATCC - Key offerings; Exhibits126: Akron Biotechnology LLC - Overview; Exhibits127: Akron Biotechnology LLC - Product / Service; Exhibits128: Akron Biotechnology LLC - Key offerings; Exhibits129: Becton Dickinson and Co. - Overview; Exhibits130: Becton Dickinson and Co. - Business segments; Exhibits131: Becton Dickinson and Co. - Key news; Exhibits132: Becton Dickinson and Co. - Key offerings; Exhibits133: Becton Dickinson and Co. - Segment focus; Exhibits134: Bio Techne Corp. - Overview; Exhibits135: Bio Techne Corp. - Business segments; Exhibits136: Bio Techne Corp. - Key news; Exhibits137: Bio Techne Corp. - Key offerings; Exhibits138: Bio Techne Corp. - Segment focus; Exhibits139: Bionique Testing Laboratories Inc. - Overview; Exhibits140: Bionique Testing Laboratories Inc. - Product / Service; Exhibits141: Bionique Testing Laboratories Inc. - Key offerings; Exhibits142: Charles River Laboratories International Inc. - Overview; Exhibits143: Charles River Laboratories International Inc. - Business segments; Exhibits144: Charles River Laboratories International Inc. - Key news; Exhibits145: Charles River Laboratories International Inc. - Key offerings; Exhibits146: Charles River Laboratories International Inc. - Segment focus; Exhibits147: F. Hoffmann La Roche Ltd. - Overview; Exhibits148: F. Hoffmann La Roche Ltd. - Business segments; Exhibits149: F. Hoffmann La Roche Ltd. - Key news; Exhibits150: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits151: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits152: GeneCopoeia Inc. - Overview; Exhibits153: GeneCopoeia Inc. - Product / Service; Exhibits154: GeneCopoeia Inc. - Key offerings; Exhibits155: InvivoGen Corp. - Overview; Exhibits156: InvivoGen Corp. - Product / Service; Exhibits157: InvivoGen Corp. - Key offerings; Exhibits158: Lonza Group Ltd. - Overview; Exhibits159: Lonza Group Ltd. - Business segments; Exhibits160: Lonza Group Ltd. - Key news; Exhibits161: Lonza Group Ltd. - Key offerings; Exhibits162: Lonza Group Ltd. - Segment focus; Exhibits163: Merck KGaA - Overview; Exhibits164: Merck KGaA - Business segments; Exhibits165: Merck KGaA - Key news; Exhibits166: Merck KGaA - Key offerings; Exhibits167: Merck KGaA - Segment focus; Exhibits168: Norgen Biotek Corp. - Overview; Exhibits169: Norgen Biotek Corp. - Product / Service; Exhibits170: Norgen Biotek Corp. - Key offerings; Exhibits171: Sartorius AG - Overview; Exhibits172: Sartorius AG - Business segments; Exhibits173: Sartorius AG - Key news; Exhibits174: Sartorius AG - Key offerings; Exhibits175: Sartorius AG - Segment focus; Exhibits176: Thermo Fisher Scientific Inc. - Overview; Exhibits177: Thermo Fisher Scientific Inc. - Business segments; Exhibits178: Thermo Fisher Scientific Inc. - Key news; Exhibits179: Thermo Fisher Scientific Inc. - Key offerings; Exhibits180: Thermo Fisher Scientific Inc. - Segment focus; Exhibits181: Inclusions checklist; Exhibits182: Exclusions checklist; Exhibits183: Currency conversion rates for US$; Exhibits184: Research methodology; Exhibits185: Validation techniques employed for market sizing; Exhibits186: Information sources; Exhibits187: List of abbreviations